Skip to main content

Market Overview

12 Biggest Mid-Day Gainers For Friday

Share:

 

  • Stone Energy Corporation (NYSE: SGY) shares surged 16.7 percent to $14.07. Stone Energy shares have dropped 88.55 percent over the past 52 weeks, while the S&P 500 index has gained 1.45 percent in the same period.
  • Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares jumped 12.7 percent to $6.41. Stifel Nicolaus initiated coverage of Aldeyra Therapeutics with a Buy rating.
  • AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) shares climbed 12.3 percent to $3.66 as the company reported that it has signed an exclusive license agreement with Cyntec, an affiliate of Orient EuroPharma Co, for Zoptrex.
  • Kinross Gold Corporation (USA) (NYSE: KGC) gained 6.8 percent to $5.22. Macquarie upgraded Kinross Gold from Underperform to Neutral.
  • Thor Industries, Inc. (NYSE: THO) shares gained 6.6 percent to $69.04 after the company disclosed the acquisition of Jayco, Corp. for about $576 million in cash.
  • Mesoblast limited (ADR) (NASDAQ: MESO) shares rose 5.6 percent to $4.21 after the company issued an update on heart failure trial and funding of clinical operations. Mesoblast projects to do interim analysis for Phase 3 endpoints in Q1 2017
  • Netflix, Inc. (NASDAQ: NFLX) gained 5.5 percent to $96.45. Canaccord Genuity initiated coverage on Netflix with a Buy rating and a $120.00 price target.
  • Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 5.3 percent to $3.80. Macquarie upgraded Harmony Gold Mining from Underperform to Neutral.
  • Pan American Silver Corp. (USA) (NASDAQ: PAAS) shares gained 4.4 percent to $17.17. Silver futures gained 4.6 percent to trade at $19.49 an ounce.
  • Randgold Resources Ltd. (ADR) (NASDAQ: GOLD) gained 4.3 percent to $116.78. Macquarie upgraded Randgold from Neutral to Outperform. Gold futures gained 1.4 percent to $1,338.90 an ounce.
  • Galectin Therapeutics Inc (NASDAQ: GALT) shares rose 3.4 percent to $1.52. Roth Capital assumed Galectin Therapeutics with a Buy rating.
  • Array Biopharma Inc (NASDAQ: ARRY) shares rose 3.1 percent to $3.67 after the company reported the submission of NDA for binimetinib to the FDA.
 

Related Articles (SGY + ALDX)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com